SCHEMBL14099423

SCHEMBL14099423

c1ccc(N(c2ccccc2)c2ccc(N(c3ccccc3)c3ccc4ccccc4c3)c3nc4ccccc4nc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.38
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35
ACHE P22303 1/20 0.35
TDP1 Q9NUW8 2/20 0.33
NCF1 P14598 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
INSR P06213 1/20 0.32
IGF1R P08069 1/20 0.32
PIN1 Q13526 1/20 0.32
HTR3A P46098 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14099523 1.00 NQO2 (0.38) NQO2KDM4EALDH1A1MAPTGLA
SCHEMBL14099253 0.89 KDM4E (0.36) NQO2KDM4EALDH1A1GLAHPGD
SCHEMBL14099512 0.86 MAPT (0.42) NQO2KDM4EALDH1A1MAPTGLA
SCHEMBL14492012 0.86 PRMT5 (0.39) KDM4EMAPTCYP3A4LMNAESR1
SCHEMBL14099421 0.84 KDM4E (0.35) KDM4EALDH1A1MAPTTDP1L3MBTL1
SCHEMBL14099514 0.84 KDM4E (0.35) KDM4EALDH1A1MAPTTDP1L3MBTL1
SCHEMBL14374525 0.83 ALDH1A1 (0.35) KDM4EALDH1A1MAPTTDP1L3MBTL1
SCHEMBL14374560 0.83 ALDH1A1 (0.35) KDM4EALDH1A1MAPTTDP1L3MBTL1
SCHEMBL14374549 0.81 ALDH1A1 (0.34) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL700417 0.81 ALDH1A1 (0.40) KDM4EALDH1A1MAPTHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956011-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2008-08-13 EP disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME KCNH2, SLC7A5, KCNH3 NQO2 171/4885KDM4E 1016/4885ALDH1A1 1210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.